Manchester University NHS Foundation Trust - Wythenshawe Hospital

The Manchester University NHS Foundation Trust - Wythenshawe Hospital incorporates Wythenshawe Hospital in Manchester https://mft.nhs.uk//
Case Ascertainment for 2018-19 and 2019-20 was calculated for the entire trust.

View Trust Services

This trust offers the following services:

  • Diagnostic and pre-operative services:
    • On-site PET-CT facilities
    • On-site Cardio-Pulmonary Exercise Testing (CPET) facilities
    • Age Specific Genetic Testing for Lynch Syndrome
  • Surgical services:
    • On-site hepatobiliary surgical team
    • On-site thoracic surgical team
    • Robotic surgery
  • Advanced disease services:
    • Dedicated Specialist Advanced MDT
    • Complex vascular reconstruction
    • Extended lymphadenectomy
  • Support service facilities:
    • Dedicated nurses for ERAS services
    • 7-day access to face-to-face palliative care services

Data Quality

All Patients: Trust Network National
Number of patients in Audit 144 1862 35779
Case ascertainment (%) Good Good Good
Data completeness of:
– Pre-treatment TNM (%) 79 87 86
– Performance status (%) 98 89 89
Patients having major resection: Trust Network National
Number of patients in Audit 110 994 19631
ASA grade 1 (%) 6 16 9
ASA grade 2 (%) 43 44 53
ASA grade 3 (%) 46 36 31
ASA grade 4+ (%) 4 2 2
ASA grade not recorded (%) 1 2 4
Data completeness of:
7 Audit items for risk-adjustment (%) 98 95 87

Key:

> 80%
50 - 80%
< 50%

Management of all patients

All Patients: Trust Network National
Number of patients in Audit 144 1862 35779
Seen by Clinical Nurse Specialist (%) 99 92 88

Management of patients having major resection

Patients having major resection: Trust Network National
Number of patients in Audit 110 994 19614
Distant metastases (%) 3 4 5
Urgent or emergency surgery (%) 11 12 15
At least 12 lymph nodes excised (%) 97 89 84
Laparoscopic surgery attempted (%) 64 63 72
Risk-adjusted length of stay > 5 days (%) 47 60 55
Patients having major resection for stage III colon cancer: Trust Network National
Number of patients in audit 70 N/A 10747
Adjuvant chemotherapy (%) 56 N/A 62
Patients receiving chemotherapy after major resection for stage III colon cancer: Trust Network National
Number of patients in audit N/A N/A 6608
Severe acute toxicity after adjuvant chemotherapy (%) N/A N/A 22

Rectal cancer patients

Patients having major resection: Trust Network National
Number of patients in Audit 26 N/A 4251
Neoadjuvant therapy (%) 18 N/A 33
Circumferential resection margin: Recorded (%) 96 96 89
Circumferential resection margin: Negative (%) 96 89 83
Rectal volume 22 N/A 4377
Patients in APER/Hartmanns estimate: Trust Network National
Number of patients in APER/Hartmanns estimate 95 809 19644
APER/Hartmanns (%) 42 43 37

Compare trust outcomes